cebranopadol (GRT6005) - Assertio, Grunenthal
tramadol hydrochloride - Generic mfg.
Assessment of Abuse Potential of Cebranopadol in Humans (clinicaltrials.gov) - Feb 25, 2022 - P1 | N=50 | Recruiting | Sponsor: Tris Pharma, Inc. 
New P1 trial • Addiction (Opioid and Alcohol)
http://clinicaltrials.gov/ct2/show/NCT05256108
 
Feb 25, 2022
 
Prev Next